Rubenstein David M.
Insider CIK 1543895 · CG See Remarks, Director, 10% owner · MRNA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CG Carlyle Group Inc. | G Gift | 2026-09-11 | 2026-09-11 | 100,000 | — | $0 | 27,299,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2026-09-11 | 2026-09-11 | 400,000 | $42.74 | $17.10M | 26,899,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2026-09-11 | 2026-09-11 | 400,000 | $42.74 | $17.10M | 26,899,644 | SEC↗ |
| CG Carlyle Group Inc. | G Gift | 2026-09-11 | 2026-09-11 | 100,000 | — | $0 | 27,299,644 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2026-05-06 | 2026-05-08 | 9,681 | — | $0 | 9,681 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2026-05-06 | 2026-05-08 | 2,092 | — | $0 | 2,092 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise deriv | 2026-04-30 | 2026-05-04 | 8,116 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise | 2026-04-30 | 2026-05-04 | 8,116 | — | $0 | 9,643 | SEC↗ |
| CG Carlyle Group Inc. | G Gift | 2026-03-19 | 2026-03-20 | 100,000 | — | $0 | 27,899,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2026-03-19 | 2026-03-20 | 500,000 | $46.68 | $23.34M | 27,399,644 | SEC↗ |
| CG Carlyle Group Inc. | G Gift | 2025-12-10 | 2025-12-12 | 625,000 | — | $0 | 28,624,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2025-12-10 | 2025-12-12 | 625,000 | $56.55 | $35.34M | 27,999,644 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise deriv | 2025-08-05 | 2025-08-06 | 850 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise | 2025-08-05 | 2025-08-06 | 850 | — | $0 | 1,527 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise deriv | 2025-04-30 | 2025-05-01 | 677 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2025-04-30 | 2025-05-01 | 12,756 | — | $0 | 12,756 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2025-04-30 | 2025-05-01 | 8,116 | — | $0 | 8,116 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise | 2025-04-30 | 2025-05-01 | 677 | — | $0 | 677 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2024-08-05 | 2024-08-07 | 850 | — | $0 | 850 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2024-08-05 | 2024-08-07 | 5,051 | — | $0 | 5,051 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2024-08-05 | 2024-08-07 | 4,065 | — | $0 | 4,065 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2024-08-05 | 2024-08-07 | 677 | — | $0 | 677 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2022-06-06 | 2022-06-06 | 2,000,000 | $38.67 | $77.34M | 29,249,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2021-11-09 | 2021-11-10 | 2,000,000 | $58.00 | $116.00M | 31,249,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2021-08-13 | 2021-08-13 | 1,895,200 | $47.80 | $90.59M | 33,254,444 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2021-08-13 | 2021-08-13 | 4,800 | $48.86 | $234.5K | 33,249,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2021-08-11 | 2021-08-13 | 2,100,000 | $46.46 | $97.57M | 35,149,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2021-05-18 | 2021-05-19 | 2,000,000 | $41.76 | $83.52M | 37,249,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2021-03-11 | 2021-03-12 | 3,000,000 | $35.80 | $107.40M | 39,249,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2020-12-10 | 2020-12-11 | 750,000 | $29.05 | $21.79M | 42,249,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2020-11-24 | 2020-11-24 | 2,000,000 | $27.30 | $54.60M | 42,999,644 | SEC↗ |
| CG Carlyle Group Inc. | S Sale | 2020-11-09 | 2020-11-10 | 2,000,000 | $27.32 | $54.64M | 44,999,644 | SEC↗ |
| CG Carlyle Group Inc. | C Conversion deriv | 2020-01-01 | 2020-01-03 | 46,999,644 | — | $0 | 0 | SEC↗ |
| CG Carlyle Group Inc. | C Conversion | 2020-01-01 | 2020-01-03 | 46,999,644 | — | $0 | 46,999,644 | SEC↗ |